Akamai Technologies vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 76)

Akamai Technologies

LeaderConsumer Technology

Enterprise

Cambridge MA edge cloud (NASDAQ: AKAM) at $3.99B 2024 revenue with security $2B+ first to surpass CDN; 365K+ servers in 135+ countries Q2 2025 cloud infra growing 30% competing with Cloudflare for enterprise web security and edge cloud.

AI VisibilityBeta
Overall Score
B76
Category Rank
#102 of 290
AI Consensus
49%
Trend
stable
Per Platform
ChatGPT
87
Perplexity
67
Gemini
68

About

Akamai Technologies is a Cambridge, Massachusetts-based edge cloud company — publicly traded on NASDAQ (NASDAQ: AKAM) as an S&P 500 company — providing enterprises with content delivery (CDN), cybersecurity, and cloud computing services through the world's most distributed edge platform: 365,000+ servers across 4,200+ points of presence in 135+ countries. In 2024, Akamai reported $3.99 billion in revenue (5% year-over-year growth) with security products generating $2+ billion (16% growth) — the first year in the company's 27-year history that security represented the largest revenue segment. In Q2 2025, Akamai reported $1.043 billion in revenue (7% growth) with cloud infrastructure growing 30% year-over-year. The business model transformation from CDN-dominant to security-dominant to cloud-expanding reflects CEO and co-founder Dr. Tom Leighton's strategy to leverage the distributed edge network for adjacent high-growth services. Founded in 1998 by MIT professors Tom Leighton and Danny Lewin.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

76
Overall Score
90
#102
Category Rank
#9
49
AI Consensus
60
stable
Trend
stable
87
ChatGPT
99
67
Perplexity
99
68
Gemini
83
77
Claude
96
80
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.